T1	Participants 72 94	GnRH agonist treatment
T2	Participants 169 202	hormone replacement therapy (HRT)
T3	Participants 291 302	28 patients
T4	Participants 391 435	postmenopausal women with high bone turnover
T5	Participants 1107 1112	women
T6	Participants 1609 1638	women with ovarian deficiency
